Cargando…

Type III interferon drives thymic B cell activation and regulatory T cell generation

The activation of thymic B cells is critical for their licensing as antigen presenting cells and resulting ability to mediate T cell central tolerance. The processes leading to licensing are still not fully understood. By comparing thymic B cells to activated Peyer’s patch B cells at steady state, w...

Descripción completa

Detalles Bibliográficos
Autores principales: Martinez, Ryan J., Breed, Elise R., Worota, Yosan, Ashby, Katherine M., Vobořil, Matouš, Mathes, Tailor, Salgado, Oscar C., O’Connor, Christine H., Kotenko, Sergei V., Hogquist, Kristin A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: National Academy of Sciences 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9992806/
https://www.ncbi.nlm.nih.gov/pubmed/36802427
http://dx.doi.org/10.1073/pnas.2220120120
Descripción
Sumario:The activation of thymic B cells is critical for their licensing as antigen presenting cells and resulting ability to mediate T cell central tolerance. The processes leading to licensing are still not fully understood. By comparing thymic B cells to activated Peyer’s patch B cells at steady state, we found that thymic B cell activation starts during the neonatal period and is characterized by TCR/CD40-dependent activation, followed by immunoglobulin class switch recombination (CSR) without forming germinal centers. Transcriptional analysis also demonstrated a strong interferon signature, which was not apparent in the periphery. Thymic B cell activation and CSR were primarily dependent on type III IFN signaling, and loss of type III IFN receptor in thymic B cells resulted in reduced thymocyte regulatory T cell (T(reg)) development. Finally, from TCR deep sequencing, we estimate that licensed B cells induce development of a substantial fraction of the T(reg) cell repertoire. Together, these findings reveal the importance of steady-state type III IFN in generating licensed thymic B cells that induce T cell tolerance to activated B cells.